
Ambuja Q1 consolidated PAT down 32% YoY to ₹660 Cr; revenue off 8%, margins soft
Ambuja Cements opened FY27 with a soft print. Consolidated revenue from operations fell ~7.7% YoY to ₹9,474 Cr (₹9,500 Cr including grants) and total profit after tax dropped ~32% to ₹660 Cr (owners' share ₹577 Cr, EPS ₹2.32) versus the ₹969.66 Cr our records carry for Q1FY26 — a decline of ~26% even after adjusting for the small one-offs on both sides (₹24 Cr ACC severance charge this quarter, ₹40 Cr indemnification gain a year ago). On the filing's own restated comparative (₹1,041 Cr) the fall is steeper, ~37%. Standalone PAT was ₹504 Cr on revenue of ₹6,320 Cr. This is a weak quarter judged on the primary YoY axis, regardless of basis. The QoQ optics are misleading and must be read with care. PAT looks down ~64% from Q4FY26's ₹1,857 Cr, but that quarter was flattered by a one-time ₹1,187 Cr deferred-tax credit and ₹750 Cr current-tax reversal tied to the Sanghi/Penna amalgamation — Q4 carried a net tax credit, whereas this quarter's tax is a normal ₹188 Cr charge. Stripping tax noise, the operating picture actually improved sequentially: EBITDA margin recovered to ~16.7% (EBITDA ~₹1,589 Cr) from a depressed ~13.4% in Q4, evidence that the management 'reset' and ₹250/tonne cost-reduction push flagged on the last call is showing early traction. But margins are still below the ~19% earned a year ago — power & fuel (₹2,389 Cr) and freight (₹2,258 Cr) remain the heavy lines and the YoY margin compression is the real story behind the profit drop. Against the bar we set pre-result, the print is broadly in line operationally: revenue of ₹9,474 Cr landed at the low end of our ₹9,500–9,700 Cr expectation and implied EBITDA/T of ~₹880 sits inside the ₹850–900 band, but the bottom line disappointed on normalized tax and thinner margins. No fresh brokerage consensus is available for a same-day print; the standing Street view remains constructive (Buy, ₹616–680 targets) on the 140 MTPA roadmap and merger synergies. Management gives no quarterly PAT guidance; its FY27 target of ~8% volume growth to 80 MnT is an annual marker that a single seasonally-soft Q1 (cement Q1 is typically below the Jan–Mar peak) neither confirms nor refutes, and the quarter notably included a temporary suspension of manufacturing at certain facilities under a 'strategic review' — a swing factor for volumes to watch. On the corporate front, the amalgamation agenda advanced: NSE/BSE issued NOCs (June 4) for the ACC and Orient mergers, and the NCLT on July 20 ordered a shareholder meeting on Sept 28, 2026 for the Orient scheme — the vehicle for the ₹100/tonne synergy story. The group also drew ₹3,900 Cr and ₹450 Cr of inter-corporate deposits from ACC and Orient at 8%. No management press release was captured with this filing to cross-check framing.
Key Highlights
- Consolidated revenue from operations ₹9,474 Cr, down ~7.7% YoY and ~13% QoQ (₹9,500 Cr incl. grants vs ₹10,289 Cr year-ago)
- Consolidated PAT ₹660 Cr (owners' ₹577 Cr, EPS ₹2.32), down ~32% YoY reported / ~26% adjusted; ~37% vs filing's restated ₹1,041 Cr base
- QoQ PAT fall (~64%) is a tax artefact: Q4FY26 held ₹1,187 Cr deferred-tax credit + ₹750 Cr current-tax reversal; this quarter tax is a normal ₹188 Cr
- EBITDA margin ~16.7% recovered from Q4's ~13.4% but below ~19% a year ago; power/fuel (₹2,389 Cr) and freight (₹2,258 Cr) the key cost lines
- Standalone PAT ₹504 Cr on revenue ₹6,320 Cr; standalone and consolidated both point weaker YoY (no material divergence in direction)
- Orient merger: NCLT ordered Sept 28, 2026 shareholder meeting; ACC/Orient schemes got NSE/BSE NOCs on June 4, 2026
- Temporary suspension of manufacturing at certain plants under strategic review; ₹4,350 Cr of 8% inter-corporate deposits drawn from ACC/Orient
Price Impact
More from AMBUJACEM